TrialJournal of diabetes research2024

A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study).

Hae Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.